Standard Biotools (LAB) Other Operating Expenses (2010 - 2026)

Standard Biotools (LAB) has reported Other Operating Expenses for 17 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 937.64% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 11.19% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 82.7% from the prior year.
• Other Operating Expenses was $2.8 million for Q2 2026 at Standard Biotools, up from $645000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $14.3 million in Q1 2022 and troughed at -$50000.0 in Q1 2023.
• A 5-year average of $2.3 million and a median of $1.2 million in 2025 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 18388.89% in 2023, down 100.35% in 2023.
• Over 5 years, Other Operating Expenses stood at $9000.0 in 2022, then surged by 53177.78% to $4.8 million in 2023, then plunged by 97.37% to $126000.0 in 2024, then surged by 411.9% to $645000.0 in 2025, then jumped by 335.97% to $2.8 million in 2026.
• The last three Other Operating Expenses figures came in at $2.8 million (Q2 2026), $645000.0 (Q4 2025), and $43000.0 (Q3 2025), per Business Quant data.